|
|
Dear Colleague:
I am pleased to announce the anchor event in our Global Drug
Development Series. This event will bring together the experts and delegates
from our industry-recognized annual China and India conferences, as well as
those involved in projects in Greater Asia, Russia, Eastern Europe and Latin
America. Faculty members and delegates will focus on strategies and approaches
to navigating the opportunities and challenges of drug discovery and development
in emerging regions.
The 2007 Global R&D Congress will be a two-day interactive forum
of in-depth case studies, roundtable and panel discussions, pre-conference
tutorials, keynote presentations, and break-out sessions by function area.
Please note that there are three (3) tracks being offered:
Track A = Basic Research & Discovery
Track B = Pre-Clinical Development
Track C = Clinical Operations
Please see below for a list of speakers that are presenting.
Despite there being three distinct tracks, you will see in the agenda that we
are taking great effort to bring experts and delegates from different function
areas together both at the beginning and end of each day for discussion.
I look forward to seeing you in Philadelphia!
Sincerely,
Conference Director, Pharmaceutical Strategy Series
Cambridge Healthtech Institute
P.S. Register by
April 6th & Save up to $200
Distinguished Faculty:
-
Lee
Babiss, Ph.D., Vice President, Preclinical Research
and Development, Roche
-
Mark A.
Bach, Ph.D., Vice President, Clinical Research
Operations Worldwide, Merck
& Co.
-
Balu
Balasubramanian, Ph.D., Director, Discovery
Chemistry, Bristol-Myers
Squibb Co.
-
Steve
Bjornson, MBA, Associate Director, Discovery
Research Strategy, Wyeth
Pharmaceuticals
-
Beth
Bookland, Ph.D., Director, Clinical Operations,
Procter & Gamble
Pharmaceuticals
-
Duke
Dunant, Senior Project Manager, Global
Distribution, Amgen
-
Subhash
Dhawan, Ph.D., Senior Investigator and Chief,
Immunopathogenesis Section, CBER,
FDA
-
Parimal
R. Desai, Vice President, Analytical and Quality
Sciences, Wyeth
Pharmaceuticals
-
Rakesh
Dixit, Ph.D., DABT, Senior Director and Head,
Toxicology, MedImmune,
Inc.
-
Duke Dunant, Director,
Clinical Supply Chain, Amgen
-
Sara
Friedlander, Ph.D., Director, Global Strategic
Sourcing, Bristol-Myers
Squibb Co.
-
Kenneth
A. Getz, Ph.D., Senior Research Fellow, Tufts
Center for the Study of Drug
Development and
Chairman and Founder, CISCRP
-
Simon
Greenwood, Ph.D., Senior Manager, Business
Development, Genentech,
Inc.
-
Martin Hauses,
Outsourcing Manager, Merck
KGaA
-
Katsumi
Ishiguro, Manager, Licensing & Business
Development, Kaken
Pharmaceutical Co., Ltd.
-
Mak Jawadekar, Ph.D.,
Director, WWPM, Pfizer Global
R&D
-
Gregory
E. Kalbaugh, Director and Counsel for
Intellectual Property, Trade and
Labor, US-India Business
Council, US
Chamber of Commerce
-
Ismail Kola, Ph.D., Senior Vice
President, Basic Research, Merck
& Co.
-
Sundeep
Lal, Ph.D., MBA, Senior Director, New Products
/ Licensing, Global Human Health, Merck
& Co.
|
-
Lily W. Lee,
Ph.D., Vice President, Head of Asia Pacific,
Johnson and Johnson
-
Matthew Levy,
Director, Protein & Small Molecule
Division, Applied
Biosystems - China
-
Michael N.
Liebman, Ph.D., Executive Director,
Windber Research Institute
-
Robert Maguire,
M.D., Vice President, Clinical
Development and Chief of Operations, Wyeth
-
Joel S. Marcus, Chief Executive
Officer, Alexandria Real
Estate Equities, Inc.
-
Laura Meyerson,
Ph.D., Vice President and Head of
Biometrics, Biogen
Idec
-
Suresh Poosala
DVM, Ph.D., Chief of Comparative
Medicine and Animal Program Director, NIH
-
Ted Quiroz,
Ph.D., Director, Clinical Supply Chain,
Amgen
-
Judith Reece,
Ph.D., Director, R&D Strategic Planning,
Development Affairs, AstraZeneca
-
James Resch,
Ph.D., Director, Strategic Planning, Global
Discovery Affairs, AstraZeneca
-
Glenn Rice,
Ph.D., Chief Executive Officer and
President, Bridge
Pharmaceuticals, Inc.
-
Nikolay Savchuk,
Ph.D., President & Chief Executive
Officer, ChemDiv,
Inc.
-
Kenneth Savin,
Ph.D., Head of the Discovery Chemistry
Global Operations Group, Discovery Chemistry, Eli
Lilly
-
Romi Singh,
Ph.D., Executive Director, Global
Regulatory Affairs, Amgen
Inc.
-
Whaijen Soo,
M.D., Ph.D., Senior Vice President, Medical
Research, Biogen
Idec
-
Gangadhar
Sunkara, Ph.D., MBA, Associate Director,
Exploratory Development, Novartis
-
Fabio A. Thiers,
M.D., Research Fellow, MIT Center for
Biomedical Innovation, Harvard-MIT
Division of
Health Sciences &
Technology
-
Patricia Turney,
Director, R&D Strategic Operations,
Amgen Inc.
-
Kamesh Venugopal, President, Torrent
Pharmaceuticals
Ltd.
-
Gene Williams, Chief Executive
Officer, Cambridge
Healthtech Associates
|
|
